Approvals/CIMA-AEMPS/AMBRISENTAN AUROVITAS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

AMBRISENTAN AUROVITAS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a578d4cd7a10cb2f
Drug Cima Aemps Name: AMBRISENTAN AUROVITAS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 88446
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2023-03-15
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Aurovitas Spain, S.A.U.

AMBRISENTAN

5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 15, 2023

Approval ID

a578d4cd7a10cb2f

Type

Standard